Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Nutrien
NTR
|
+$111M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$37.6M |
| 3 |
Becton Dickinson
BDX
|
+$29.5M |
| 4 |
Alibaba
BABA
|
+$28.3M |
| 5 |
NXP Semiconductors
NXPI
|
+$24.5M |
Top Sells
| 1 |
Apple
AAPL
|
+$431M |
| 2 |
Microsoft
MSFT
|
+$315M |
| 3 |
Amazon
AMZN
|
+$278M |
| 4 |
Meta Platforms (Facebook)
META
|
+$170M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$150M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Healthcare | 14.49% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Industrials | 10.4% |
| 5 | Communication Services | 10.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABAX
1426
DELISTED
Abaxis Inc
ABAX
| $2.79M | ﹤0.01% |
39,500
+800
| +2% | +$56.5K |
|
1427
Forward Air
FWRD
$924M
| $2.79M | ﹤0.01% |
52,700
+1,100
| +2% | +$58.2K |
|
1428
CONMED
CNMD
$1.6B
| $2.77M | ﹤0.01% |
43,800
+2,100
| +5% | +$133K |
|
1429
HNI Corp
HNI
$2.08B
| $2.77M | ﹤0.01% |
76,800
| – | – |
|
1430
Heron Therapeutics
HRTX
$227M
| $2.77M | ﹤0.01% |
100,300
+1,800
| +2% | +$49.7K |
|
|
GPOR
1431
DELISTED
Gulfport Energy Corp.
GPOR
| $2.77M | ﹤0.01% |
286,558
+11,300
| +4% | +$109K |
|
1432
Sangamo Therapeutics
SGMO
$151M
| $2.76M | ﹤0.01% |
145,360
+2,900
| +2% | +$55.1K |
|
1433
Virtu Financial
VIRT
$3.06B
| $2.76M | ﹤0.01% |
83,700
+2,500
| +3% | +$82.5K |
|
|
CZR
1434
DELISTED
Caesars Entertainment Corporation
CZR
| $2.76M | ﹤0.01% |
245,360
+2,500
| +1% | +$28.1K |
|
1435
Genworth Financial
GNW
$3.56B
| $2.75M | ﹤0.01% |
972,486
+103,300
| +12% | +$292K |
|
|
ALEX
1436
Alexander & Baldwin
ALEX
$1.32B
| $2.74M | ﹤0.01% |
118,620
+40,520
| +52% | +$937K |
|
1437
B&G Foods
BGS
$358M
| $2.74M | ﹤0.01% |
115,800
+2,500
| +2% | +$59.2K |
|
|
ANAT
1438
DELISTED
American National Group, Inc. Common Stock
ANAT
| $2.74M | ﹤0.01% |
23,413
| – | – |
|
1439
Artisan Partners
APAM
$3.18B
| $2.74M | ﹤0.01% |
82,200
+1,800
| +2% | +$59.9K |
|
|
EPAY
1440
DELISTED
Bottomline Technologies Inc
EPAY
| $2.73M | ﹤0.01% |
70,500
+3,100
| +5% | +$120K |
|
1441
Papa John's
PZZA
$1.63B
| $2.71M | ﹤0.01% |
47,300
+1,800
| +4% | +$103K |
|
|
LQ
1442
DELISTED
La Quinta Holdings Inc.
LQ
| $2.71M | ﹤0.01% |
143,300
| – | – |
|
1443
MRC Global
MRC
$1.23B
| $2.71M | ﹤0.01% |
164,649
+7,500
| +5% | +$123K |
|
1444
First Hawaiian
FHB
$3.17B
| $2.7M | ﹤0.01% |
97,167
+3,300
| +4% | +$91.8K |
|
1445
Helios Technologies
HLIO
$1.8B
| $2.69M | ﹤0.01% |
50,300
+9,900
| +25% | +$530K |
|
1446
Synaptics
SYNA
$2.73B
| $2.69M | ﹤0.01% |
58,900
| – | – |
|
1447
Otter Tail
OTTR
$3.5B
| $2.69M | ﹤0.01% |
62,100
+2,500
| +4% | +$108K |
|
1448
NBT Bancorp
NBTB
$2.24B
| $2.69M | ﹤0.01% |
75,800
+2,500
| +3% | +$88.7K |
|
1449
Interface
TILE
$1.71B
| $2.69M | ﹤0.01% |
106,700
| – | – |
|
|
NAV
1450
DELISTED
Navistar International
NAV
| $2.69M | ﹤0.01% |
76,900
+2,100
| +3% | +$73.4K |
|